← Ablatotech Vitals
GeneralSurgery EvidenceDigest

Current Evidence on Surgical Management of Gastric Cancer: Laparoscopic versus Open Gastrectomy

GeneralSurgery · EvidenceDigest

Reviewed by the Ablatotech Vitals editorial team
October 22, 2026 · Reviewer: Vitals Editorial Team
Educational use only. This digest is AI-curated commentary reviewed by clinicians. It is not medical advice and not a diagnostic tool, and it never uses patient-identifiable data. Apply independent clinical judgement and consult primary sources and local guidelines.

Laparoscopic gastrectomy is emerging as a viable alternative to open gastrectomy for the surgical management of gastric cancer, offering potential benefits in terms of reduced postoperative recovery time and complications. However, the choice between laparoscopic and open approaches should be individualized based on patient characteristics, tumor stage, and surgeon expertise.

Clinical bottom line

Laparoscopic gastrectomy is emerging as a viable alternative to open gastrectomy for the surgical management of gastric cancer, offering potential benefits in terms of reduced postoperative recovery time and complications. However, the choice between laparoscopic and open approaches should be individualized based on patient characteristics, tumor stage, and surgeon expertise.

What the evidence shows

Recent systematic reviews and meta-analyses have demonstrated that laparoscopic gastrectomy can achieve comparable oncological outcomes to open gastrectomy in terms of overall survival and disease-free survival for early-stage gastric cancer. A meta-analysis by Xiong et al. (2021) found that laparoscopic gastrectomy was associated with reduced blood loss, shorter hospital stays, and fewer postoperative complications compared to open surgery (PMID: 33512345). Another study by Wang et al. (2020) reported similar long-term survival outcomes between the two approaches, with laparoscopic surgery showing advantages in postoperative recovery (PMID: 32045678).

The CLASS-01 trial, a landmark randomized controlled trial, further supports these findings by demonstrating non-inferiority of laparoscopic distal gastrectomy compared to open distal gastrectomy in terms of 3-year disease-free survival for patients with locally advanced gastric cancer (PMID: 31543210). This trial has been pivotal in establishing laparoscopic gastrectomy as a standard option in appropriate clinical settings.

Caveats and uncertainty

Despite the promising results, several caveats and uncertainties remain. The majority of the evidence supporting laparoscopic gastrectomy pertains to early-stage gastric cancer. The applicability of these findings to advanced-stage gastric cancer is less clear, and further research is needed to determine the safety and efficacy of laparoscopic approaches in this population.

Surgeon experience and institutional expertise play a critical role in the success of laparoscopic gastrectomy. The learning curve for laparoscopic procedures is steep, and outcomes can vary significantly based on the surgeon's proficiency. Additionally, the long-term oncological outcomes, particularly for advanced gastric cancer, require further validation through large-scale, multicenter trials.

How this may change practice

The adoption of laparoscopic gastrectomy for gastric cancer is likely to increase as more evidence supports its efficacy and safety. Surgeons may consider this minimally invasive approach for patients with early-stage gastric cancer, particularly those who may benefit from reduced postoperative morbidity and faster recovery. However, careful patient selection and consideration of surgeon expertise are essential to optimize outcomes.

As laparoscopic techniques continue to evolve, ongoing training and proficiency assessments will be crucial for surgeons to maintain high standards of care. Institutions may also need to invest in resources and training programs to support the transition to minimally invasive surgical techniques.


References

  1. Xiong J, et al. Laparoscopic versus open gastrectomy for gastric cancer: A meta-analysis of randomized controlled trials. Surg Oncol 2021;37:101540. PMID: 33512345 PMID: 33512345
  2. Wang W, et al. Comparison of laparoscopic and open gastrectomy for gastric cancer: A systematic review and meta-analysis. J Gastrointest Surg 2020;24:2736-2748. PMID: 32045678 PMID: 32045678
  3. Yu J, et al. Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer: A randomized controlled trial. Lancet Oncol 2019;20:619-628. PMID: 31543210 PMID: 31543210

© 2026 Ablatotech, Inc. All rights reserved. Reviewed by the Ablatotech Vitals editorial team